Shaping the Future of
Pharmaceutical Care
For decades, Afflatus Pharma has dedicated itself to excellence in healthcare. Explore our timeline of breakthrough formulations, manufacturing milestones, and our unwavering commitment to global wellness.
15+
Years Experience
200+
Formulations
WHO
GMP Certified
100% Compliant
Rigorous QA Metrics
Global Supply
Exporting Excellence
Milestones That
Shape Our Story
Trace our evolutionary timeline from a dedicated regional healthcare provider founded in 1988 to a multi-facility global pharmaceutical manufacturer.
Foundation of Healthcare Vision
The journey of Afflatus Pharmaceuticals began with a commitment to providing quality and affordable healthcare products. The foundation was laid with a vision to contribute to the pharmaceutical and healthcare industry through ethical business practices and customer-focused solutions.
Growth & Diversification
Over the years, the organization expanded its portfolio to include Pharmaceutical, Ayurvedic, Nutraceutical, Protein Supplement, and Cosmetic products. Continuous investment in quality systems, research, and manufacturing capabilities helped strengthen its market presence.
Establishment of Modern Manufacturing Facilities
To support its growing operations, the company developed advanced manufacturing facilities equipped with modern technology and quality control systems, ensuring compliance with national and international quality standards.
Expansion Through Unit 1
The company strengthened its manufacturing capabilities through Unit 1, dedicated to the production of Ayurvedic, Nutraceutical, Protein Supplement, and Cosmetic products, enabling a broader healthcare product portfolio
Launch of Unit 2 (Bahalgarh, Sonipat)
A major milestones was achieved with the commencement of Unit 2 at Bahalgarh, Sonipat, Haryana. The facility was established for the manufacturing of Dry Powder Injections and Dry Syrups, enhancing the company's pharmaceutical manufacturing capabilities and supporting domestic as well as international business opportunities.
Expansion Into Tablet & Capsule Production
To strengthen its pharmaceutical portfolio, the company expanded its manufacturing capabilities by adding dedicated Tablet and Capsule production sections. This expansion enabled Afflatus Pharmaceuticals to cater to a broader range of therapeutic segments and customer requirements.
Addition of Advanced Sterile Manufacturing Sections
In 2025, the company further enhanced its manufacturing infrastructure with the addition of Liquid Injection, Eye/Ear Drops, and Pre-Filled Syringe (PFS) sections. These advanced facilities were established to support the production of high-quality sterile formulations while meeting evolving market demands and regulatory standards.
Present Day
Today, Afflatus Pharmaceuticals Pvt. Ltd. continues to grow as a diversified healthcare manufacturing company, offering third-party manufacturing, contract manufacturing, private labeling, government and institutional supplies, exports, and PCD Pharma Franchise services. Under the leadership of Mr. Nishchal Pruthi, Managing Director, the company remains committed to innovation, quality, and improving healthcare outcomes across markets.
Looking Ahead
With a focus on technological advancement, regulatory compliance, and customer satisfaction, Afflatus Pharmaceuticals aims to expand its product portfolio, strengthen global partnerships, and emerge as a trusted name in the healthcare industry worldwide.s